Imashil 100mg Tablet
Marketer
Shilpa Medicare Ltd
Salt Composition
Imatinib mesylate (100mg)
Overview Imashil 100mg Tablet
Imshil 100mg tablets are indicated for various cancers. Primary applications include hematologic malignancies (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial for cancer cell proliferation and metastasis. This medication is also employed in dermatofibrosarcoma protuberans and aggressive systemic mastocytosis. Administer with food, consistently at the same time daily for optimal efficacy. Treatment duration is individualized and depends on response. Incorrect usage or overdose can lead to severe adverse events. Therapeutic benefits may not be apparent for weeks or months; discontinue only under physician guidance. Common side effects include swelling, nausea, vomiting, muscle spasms, musculoskeletal discomfort, diarrhea, skin rash, tiredness, and stomach pain. Report unexplained rapid weight gain. Regular blood count and liver function monitoring are often recommended. Avoid activities requiring alertness if dizziness or blurred vision occur. Significant drug interactions are possible; disclose all medications to your healthcare provider. Avoid conception during treatment; effective contraception is crucial for both partners.
Uses of Imashil 100mg Tablet
Oncological Management
Major Benefits of Imashil 100mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Imashil 100mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Imashil 100mg Tablet:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Imashil 100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 100mg Imashil tablet whole; avoid chewing, crushing, or breaking it. Take it with a meal.
How Imashil 100mg Tablet works:
Imashil 100mg tablets combat cancer by targeting the bcr-abl tyrosine kinase protein enzyme. This enzyme drives the uncontrolled growth of cancerous cells. The drug's mechanism involves suppressing this growth and triggering programmed cell death (apoptosis) specifically in bcr-abl-positive cancer cells, thereby hindering or halting cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Imashil 100mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Imashil 100mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing it may occur exceptionally in life-threatening circumstances where benefits outweigh potential harm, at the physician's sole discretion. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Imashil 100mg Tablets is likely unsafe. Limited evidence indicates potential transfer to breast milk, posing a risk to infants. Nursing mothers should discontinue breastfeeding during treatment and for two weeks following cessation of the medication.
DrivingUNSAFE
Driving ability may be impaired by the use of Imashil 100mg Tablets, which may produce side effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Imashil 100mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Imashil 100mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Imashil 100mg Tablet :
Omit any missed Imashil 100mg Tablet dose; resume your usual regimen. Avoid taking a double dose.
Facts to Know About Imashil 100mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzanilide Derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently